Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Patent
1998-04-17
2000-08-29
Elliot, George C.
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
435 6, 435375, 514 44, 536 2431, C07H 2100
Patent
active
061110949
ABSTRACT:
The present invention provides compositions and methods for detecting and modulating levels of intercellular adhesion molecule-1 (ICAM-1) proteins, including human ICAM-1.
REFERENCES:
patent: 5514788 (1996-05-01), Bennett et al.
patent: 5580969 (1996-12-01), Hoke et al.
patent: 5591623 (1997-01-01), Bennett et al.
patent: 5789573 (1998-08-01), Baker et al.
patent: 5843738 (1998-12-01), Bennett et al.
patent: 5852188 (1998-12-01), Cook
Manoharan et al. Nucleosides & Nucleotides 14(3-5):969-973, 1995.
Condon et al. Fabseb Journal 8(4-5): pA972,#5626, 1994.
Sanghvi, Y. Antisense Research & Applications, CH 15, pp. 274-285, CRC Press, 1993.
Walden et al. PNAS 85: 5011-5015, 1988.
Martin, V.P. Helvetica Chimica Acta 78:486-504, 1995.
Branch TIBS 23:45-50, 1998.
Crooke Ch 1 in Antisense Research & Application Syringes, NY, 1998 pp. 1-50.
Wegner et al., "Intercellular Adhesion Molecule-1 (ICAM-1) in the Pathogenesis of Asthma", Science, 1990, 247, 456.
Van de Stolpe et al., "Intercellular adhesion molecule-1", J. Mol. Med., 1996, 74, 13-33.
Albelda, et al., "Adhesion molecules and inflammatory injury", FASEB J., 1994, 8, 504.
Ballantyne et al., "Nucleotide sequence of the cDNA for murine intercellular adhesion molecule-1 (ICAM-1)", Nucleic Acids Research, 1989, 17, 5853.
Ballantyne et al., "Characterize of the Murine Icam-1 Gene", Genomics, 1992, 14, 1076.
Bennett et al., "An ICAM-1 Antisense Oligonucleotide Prevents and Reverses Dextran Sulfate Sodium-Induced Colitis in Mice", J. Pharm. Exp. Therapeutics, 1997, 280, 988.
Bennett et al., "Inhibition of Endothelial Cell Adhesion Molecule Expression with Antisense Oligonucleotides", J. Immunol., 1994, 152, 3530.
Cosimi et al., "In Vivo Effects of Monoclonal Antibody To ICAM-1 (CD54) In Nonhuman Primates With Rental Allografts.sup.1 ", J. Immunol., 1990, 144, 4604.
Isobe et al., "Specific Acceptance of Cardiac Allograft After Treatment with Antibodies to ICAM-1 and LFA-1", Science, 1992, 255, 1125.
Staunton et al., "Primary Structure of ICAM-1 Demonstrates Interaction between Members of the Immunoglobulin and Integrin Supergene Families", Cell, 1988, 52, 925.
Stepkowski et al., "Blocking of Heart Allograft Rejection by Intercellular Adhesion Molecule-1 Antisense Oligonucleotides Alone or in Combination with Other Immunosuppressive Modalities.sup.1 ", J. Immunol. 1994, 153, 5336.
Bennett C. Frank
Condon Thomas P.
Flournoy Shin Cheng
Elliot George C.
Epps Janet
Isis Pharmaceuticals , Inc.
LandOfFree
Enhanced antisense modulation of ICAM-1 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Enhanced antisense modulation of ICAM-1, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Enhanced antisense modulation of ICAM-1 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1251318